Novavax, Inc. NVAX

10.63 0.03 0.28% as of 25 Sep
Market cap
$1.8B
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
745.96 933.74 578.93 1,347.19 1,526.61 804.93 81.77 102.98 185.54 265.79
Receivables
106.45 108.29 297.24 82.38 454.99 262.01 7.50 — — 0.00
Inventory
11.55 8.75 41.70 36.68 8.87 — — — — —
Other current assets
87.51 — — 237.00 174.00 181.00 8.00 16.00 18.00 22.00
Total current assets
978.28 1,128.94 1,143.89 1,703.39 2,155.12 1,248.20 97.25 119.28 203.31 287.83
Property, Plant, Equpment (Net)
44.80 138.41 305.77 294.25 225.74 179.95 11.45 28.43 35.99 40.18
Goodwill and Intangible Assets (Total)
113.46 107.48 127.45 126.33 131.48 141.10 56.74 58.51 61.44 60.90
Long-term assets (Other)
17.08 24.00 35.16 28.47 24.29 13.22 7.53 1.77 1.76 5.39
Total non-current assets
198.24 431.48 653.60 555.29 421.63 334.28 75.71 88.70 99.18 106.47
Total Assets
1,176.51 1,560.42 1,797.49 2,258.68 2,576.75 1,582.48 172.96 207.98 302.49 394.30
Notes Payable
— — — 324.88 — — — — — —
Accounts Payable
24.58 41.58 132.61 216.52 127.05 54.33 2.91 9.30 5.61 5.69
Accrued Expenses
107.17 211.17 394.67 591.16 673.73 137.39 19.95 24.63 34.69 29.59
Current Part of Capital Lease
2.51 7.01 5.14 27.20 130.53 105.86 — — — —
Current Revenue (Deferred)
140.05 675.07 241.31 370.14 1,422.94 273.23 1.68 10.01 25.63 30.08
Other current liabilities
185.65 219.60 861.41 930.06 36.06 8.86 1.26 1.60 7.75 1.06
Total current liabilities
459.95 1,154.42 1,635.14 2,459.94 2,390.32 579.67 25.80 45.54 73.68 66.41
Long Term Debt (Total)
246.30 223.41 223.94 197.70 323.46 362.12 320.61 319.19 317.76 316.34
Non-current Revenue (Deferred)
358.94 446.82 622.21 179.41 172.53 — 3.00 2.50 2.50 2.50
Non-current Liabilities (Other)
239.07 359.61 33.13 55.70 42.12 13.48 12.57 8.69 10.29 14.60
Total non-current liabilities
844.32 1,029.84 879.28 432.81 538.11 375.60 333.18 330.37 330.55 333.44
Total liabilities
1,304.27 2,184.26 2,514.42 2,892.76 2,928.43 955.27 358.97 375.91 404.23 399.85
Additional Paid In Capital
4,539.76 4,501.40 4,192.16 3,737.98 3,351.97 2,535.48 1,260.55 1,144.62 1,020.46 936.00
Common Stock (Net)
1.65 1.62 1.41 0.87 0.76 0.71 0.32 0.19 3.24 2.72
Retained Earnings
(4,568.15) (5,008.45) (4,820.95) (4,275.89) (3,617.95) (1,874.20) (1,431.80) (1,299.11) (1,114.36) (930.00)
Treasury Stock
103.02 95.85 92.27 90.66 85.10 41.81 2.58 2.45 2.45 2.45
Common Equity (Total)
(127.75) (623.84) (716.93) (634.08) (351.67) 627.21 (186.02) (167.94) (101.73) (5.55)
Shareholders Equity (Total)
(127.75) (623.84) (716.93) (634.08) (351.67) 627.21 (186.02) (167.93) (101.73) (5.55)
Shareholders Equity and Liabilities (Total)
1,176.51 1,560.42 1,797.49 2,258.68 2,576.75 1,582.48 172.96 207.98 302.49 394.30
Shares (Common)
162.58 160.42 139.51 86.04 75.84 70.95 32.35 19.22 16.16 13.56
Shareholders Equity (Tangible)
(241.22) (731.32) (844.38) (760.41) (483.15) 486.11 (242.75) (226.44) (163.17) (66.44)
Net Debt
(499.66) (710.33) (354.99) (1,149.48) (1,203.15) (442.81) 238.84 216.21 132.23 50.55
Total Debt
246.30 223.41 223.94 197.70 323.46 362.12 320.61 319.19 317.76 316.34

Fold the line items

In millions of $ except per-share values · columns are period end dates